title: Peginterferon alfa-2b for mycosis fungoides.
authors.forename: Teruki
authors.initials: T
authors.lastname: Yanagi
authors.forename: Tadamichi
authors.initials: T
authors.lastname: Shimizu
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Ujiie
authors.forename: Miki
authors.initials: M
authors.lastname: Ito
authors.forename: Riichiro
authors.initials: R
authors.lastname: Abe
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Tsuji-Abe
authors.forename: Shuhei
authors.initials: S
authors.lastname: Hige
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shimizu
mesh_terms: D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001132:Arm; D003937:Diagnosis, Differential; D004337:Drug Carriers / Q000008:administration & dosage / Q000627:therapeutic use; D019698:Hepatitis C, Chronic; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D007866:Leg; D008297:Male; D009182:Mycosis Fungoides / Q000188:drug therapy* / Q000473:pathology; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000998:Antiviral Agents; D004337:Drug Carriers; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b